Our story starts on the hospital wards. Christopher McCann, CEO & Co-Founder, was a second year medical student and computer science graduate. On hospital wards, continuous monitoring of patients has always been challenging. With twenty-four patients on a ward, the amount of data collected makes it impractical. No doctor or nurse could ever interpret so much information.
As a result, patients are only intermittently monitored. It takes about 15 minutes to collect one patient's vital sign observations manually. Christopher witnessed patients avoidably deteriorate because the warning signs were recognised late. This lead to patients suffering harm or having to stay in hospital far longer than should have been necessary. The solution seemed simple - why couldn't we monitor patients continuously and discreetly, but, crucially, then take that data and help clinicians and nurses identify who may deteriorate? Could we automatically alert healthcare staff to the patients who needed them most?
With co-founders, David Bowie and Stewart Whiting, Christopher founded snap40 to solve this and left medical school in May 2015 to grow the company full-time.
We catch deteriorating health earlier by continuously monitoring patients from a wearable arm-band and then using that data to identify which patients are at highest risk of deteriorating. snap40 combines hardware, software and data science to save lives and help health services provide better care. For the engineers, we are exception monitoring for humans.
We bootstrapped, within two years, to a built product, a major clinical study, a first contract with NHS England (via the SBRI process) and a team of five. Every single member of our team has a personal story about how snap40 could have touched their lives and that team is now growing.
We're hugely ambitious. Whilst we have seen the rise of giants in consumer internet, communications and transportation, we have not seen the same occur in health tech. We challenge that status quo. We want to care for patients and help health services around the world.
We're currently focussed on bringing our product to the UK and US but we will not stop there. Our mission is to catch deteriorating health in all people, not just those in hospital.